ALYSSA ROLLINS: Open Payments
NPI 1225569395 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,546 in 107 payments from 26 companies in 2025. Trend: 2023 $2,292 · 2024 $2,332 · 2025 $2,546
Food & beverage: $2,431Education: $115
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $444 |
| Amgen Inc. | 9 | $303 |
| Bayer Healthcare Pharmaceuticals Inc. | 15 | $299 |
| PFIZER INC. | 23 | $272 |
| ABBVIE INC. | 14 | $246 |
| Astellas Pharma US Inc | 2 | $119 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $112 |
| GlaxoSmithKline, LLC. | 5 | $98 |
| Madrigal Pharmaceuticals | 3 | $94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $65 |
Products named: AIRSUPRA, EVENITY, Kerendia, QULIPTA, ELIQUIS, CAPLYTA, PREVNAR 20, REZDIFFRA.
Industry payments across OR — which companies pay providers there.
